药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
19-Nor-5-androstenedione
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Elbasvir.
19-Nor-5-androstenedione
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Elbasvir.
19-Nor-5-androstenedione
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Elbasvir.
MMDA
Vibrio cholerae CVD 103-HgR strain live antigen
The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Salinomycin.
MMDA
(S)-Warfarin
The risk or severity of bleeding can be increased when Salinomycin is combined with (S)-Warfarin.
MMDA
Tioclomarol
The risk or severity of bleeding can be increased when Salinomycin is combined with Tioclomarol.
MMDA
Diphenadione
The risk or severity of bleeding can be increased when Salinomycin is combined with Diphenadione.
MMDA
Clorindione
The risk or severity of bleeding can be increased when Salinomycin is combined with Clorindione.
MMDA
Fluindione
The risk or severity of bleeding can be increased when Salinomycin is combined with Fluindione.
MMDA
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Salinomycin is combined with Ethyl biscoumacetate.
MMDA
(R)-warfarin
The risk or severity of bleeding can be increased when Salinomycin is combined with (R)-warfarin.
MMDA
Coumarin
The risk or severity of bleeding can be increased when Salinomycin is combined with Coumarin.
MMDA
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Salinomycin is combined with 4-hydroxycoumarin.
MMDA
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Salinomycin.
MMDA
BCG vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Salinomycin.
MMDA
Picosulfuric acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Salinomycin.
3-Methylthiofentanyl
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Alectinib.
3-Methylthiofentanyl
Ozanimod
Alectinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
3-Methylthiofentanyl
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Alectinib.
3-Methylthiofentanyl
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Alectinib.